Showing posts with label healthcare. Show all posts
Showing posts with label healthcare. Show all posts

Thursday, March 23, 2017

THE ESSENTIAL STEPS IN AN M&A TRANSACTION IN HEALTHCARE

Healthcare M&A Transactions can be extremely complex and require numerous steps, negotiations and processes to be accomplished in order for the deal to finally go through.  From Letters of Intent to Earn Out Provisions, the process can be one that relies on details and the knowledge of its inner workings in order to be accomplished properly.  The Ambulatory M&A Advisor takes a look at the essential steps in an M&A transaction and what they mean to the development of the overall deal.
Christina Van Vort, partner with the law firm of Garfunkel and Wild says that  the first essential steps in an M&A transaction come in with the Letter of Intent (LOI).
“The letters of intent can be useful to help the parties shape the transaction and to ensure that they are on the same page as to essential elements.  Sometimes, you can go directly to contracts but this often can lead to further delay as the parties begin to “work out” their issues as the draft goes back and forth,” Van Vort says.
At the outset, the parties need to make a calculation as to whether the time to put together an LOI will save time down the road.  Often times, the answer is yes and an LOI should be executed, she says, adding that either party can draft the LOI, as the non-drafting party will review and provide comments.
Jay Hardcastle, partner at the law firm of Bradley, Arant, Boult, Cummings says that usually the drafting of a letter of intent follows the execution of the non-disclosure agreement.  Meaning, once the parties have exchanged enough confidential information to determine that they want to proceed, the lawyers will draft an LOI.
“Usually lawyers will draft them because they often have a few binding provisions.  The binding provisions would typically be a “no shop” clause where the seller would agree to negotiate exclusively with the proposed buyer for a certain number of days, and another covenant to not issue any press releases or allowed to go public with the transaction until both parties are ready,” Hardcastle says.
“I think lawyers should draft them because of those issues, the rest of it is unbinding and generally just contains an outline of the proposed transaction.”
Van Vort agrees that the LOI needs to be done early in a transaction and the parties need to decide what terms, if any, will be binding even if the transaction does not proceed.
“In addition to the important listed above of a LOI, another useful purpose of the LOI is to have a document which can be taken back to a Board for approval before marching into drafting documents.”
Purchase agreement and it’s contents:  The purchase agreement is essentially a road map for getting from signing the agreement to closing, and a risk allocation covenant.  In terms of the roadmap, it will describe what each party has to do to get the transaction closed.  In terms of risk allocation, the purchase agreement will allocate risk for pre-closing and post-closing problems in accordance with the negotiated deal between the parties.
The purchase agreement will contain representations and warranties as to the state of the facility as of the closing date.  The seller should do their own due diligence to make sure that those reps and warranties are true to avoid indemnification claims based on falsity of representation.
Alice Gosfield, attorney and owner of Alice G. Gosfield and Associates says representations and warranties are different kinds of provisions in a contract that are essential to the success of the M&A process.
“Typical representations will be things like the entity has been dually authorized throughout its existence necessary for it to conduct its to conduct business as it has; the practice has maintained all of the licenses and approvals that are business.”
According to Gosfield when examining representations and warranties, the first thing to do with the representations and warranties is to ensure that the information provided is as accurate as possible and to the best of the seller’s knowledge.  Gosfield says this is important because one of the items they will be asked to represent and warrant is proof of compliance with the law in terms of Stark, Anti-kickback, false claims, and other regulations.
Gosfield says there are some essential or fundamental representations and warranties, and there are others that may be a little bit more peripheral.
“The more fundamental ones tend to be that the people representing own the business and in fact are the ones who owns the business and nobody else has claim to a portion of the business or a portion of the sale proceeds,” Gosfield says.
Also in the representations and warranties, Gosfield says tax areas are examined such as tax returns paid timely and that taxes owed by the business have been paid.
What would representations and warranties be without the process of due diligence? As with any corporate transaction, due diligence is crucial to determine liabilities, responsibilities and potential issues.
According to Van Vort, the due diligence may need to focus on licensure (and any limitations), HIPAA (e.g. and any breach notifications that have occurred and whether a HIPAA plan exists), compliance (e.g. has there been any qui tam allegations and is there a robust program) and billing practices (e.g. have there been any third party audits resulting in payback by the provider).
“However, in healthcare there are some specific and unique concerns. For example, an investigation by a governmental payor could result in a significant financial obligation of the provider.  Also, regulatory due diligence is very important because of the complexities of the health care environment,” Van Vort says.  As far as due diligence goes, Hardcastle explains that it is beneficial for both sides of the proposed transaction to perform diligence on the selling business.  This will prevent unexpected issues and possible indemnifications that could pop up post-sale.
In an M&A transaction there are various types of acquisition structures that can apply.  According to Andrew Blustein, partner at Garfunkel Wild,  selecting the right structure for one’s healthcare business depends on many factors.  Blustein says this mainly includes the type of entity and the goals of the parties.
“When for-profit providers are acquired, deals are usually structured as asset or stock sales.  Not-for-profit providers may also sell assets, or a party may acquire control in a different manner.  In short, choosing the right structure is very particular to each transaction,” Blustein says.
Hardcastle says the more common structures for physician related outpatient ventures would include asset purchases and partial purchases of interest in the entity that is the actual provider.
“In an asset purchase, the seller sells all of its assets and the buyer assumes selected liabilities.  In an interest purchase the buyer buys an interest in the actual entity.  The end result is that the existing seller still retains an interest and the resulting entity could be called a joint venture,” Hardcastle says.
Hardcastle goes on to discuss the eaarn out provision.  These provisions usually state that a seller may obtain future compensation based on future financial goals of the entity.
Hardcastle says that earn outs occur very infrequently in transactions of this type due to being problematic in the healthcare business.
“This becomes a problem when the seller has any influence over referrals, after the transaction closes.  For example, in a surgery center acquisition where the buyer is buying partial interest in the surgery center from surgeons who use the center, an earn out would be inappropriate because the surgeon’s post closing utilization would affect the ultimate purchase price,” Hardcastle says.
Article LINK

For additional information regarding Florida business sales, acquisitions and valuations, please contact Eric J. Gall at Eric@EdisonAvenue.com or 239.738.6227. Also, visit our Edison Avenue website at www.EdisonAvenue.com or my personal website at www.BuySellFLbiz.com.

Monday, November 14, 2016

What Potential Will The New Year Offer? Here's the M&A Outlook for 2017

2017’s most active sectors will be Healthcare, Telecommunications and Financials for structural reasons, while Consumer Goods & Services, Technology and Pharmaceuticals will also witness increased activity primarily due to cyclical trends.
As we stand on the threshold of 2017, it seems that a bold and bright path lies ahead for the M&A scene. Going by a new forecast released by the global law firm Baker & McKenzie, in association with Oxford Economics, fundamental drivers of global transactions are pointing to a continued strong upturn in M&A and IPOs in the coming year.
Here is the list of noteworthy projections for 2017.
  • The next three years will see global equity markets rise 18 percent to $12 trillion in value.
  • The easy monetary policies and lower oil prices will see developed economies support the collective growth in transactions. However, it will be many of the smaller or emerging economies, which will show the most dramatic growth in deal activity.
  • The current scenario where private equity firms are sitting on a record $1.1 trillion in uninvested capital could boost global transactions.
  • Cross-border transactions will take on a more significant role as companies look to gain market presence in high growth markets.
  • The top countries in forecasted M&A growth will be China (153%), Hong Kong (118%), Netherlands (110%), Mexico (89%), India (72%), United Kingdom (70%), Germany (65%), Indonesia (56%), Saudi Arabia (53%), and United Arab Emirates (50%).
  • 2017’s most active sectors will be Healthcare, Telecommunications and Financials for structural reasons, while Consumer Goods & Services, Technology and Pharmaceuticals will also witness increased activity primarily due to cyclical trends.
The forecast also estimates that the transaction peaks in 2017 and 2018 will not be as high as those before the global financial crisis and that the global economy will not experience the same bubble-like conditions as prior to 2007. However, for corporate organizations the window of opportunity for strategic cross-border M&A is now, as the structural drivers and cyclical trends such as equity prices and economic conditions such as GDP growth are ripe for deals in the coming year.
Article LINK

For additional information regarding Florida business sales, acquisitions and valuations, please contact Eric J. Gall at Eric@EdisonAvenue.com or 239.738.6227. Also, visit our Edison Avenue website at www.EdisonAvenue.com.

Thursday, October 8, 2015

Ask the Network: The Outlook for Healthcare M&A | Axial



By , Axial | 

Welcome to “Ask the Network,” where we leverage the expertise of Axial members to answer questions submitted by middle market CEOs.
This week, we posed an industry-specific question to advisors and investors on the network:

“What’s your outlook for healthcare M&A for the rest of the year?”

Jeff B. Swearingen, Edgemont Capital Partners
“The healthcare industry continues to consolidate aggressively, post Affordable Care Act.  Of recent note is Aetna’s pending purchase of Human, and Anthem’s proposed acquisition of Cigna. We see this trend continuing for the foreseeable future.  There is a three-way struggle between facilities, providers (physicians) and payors.  Market share creates negotiating leverage, operating economies of scale and access to capital, which allows each of the three to take on risk arrangements. To survive in the coming healthcare reimbursement environment, you must be consolidated with market share and have access to capital.”
Mike Moran, American HealthCare Capital
“Throughout our history, Q4 usually yields more closed transactions that any other quarter and 2015 is no exception.  With EBITDA multipliers continuing to climb and many opportunities drawing multiple offers, those equity and strategic buyers under contract are pushing to wrap up their deal flow prior to year-end after a protracted due diligence period.  In addition, with an ever changing reimbursement environment and increasing wages, business owners will continue to sell their companies.  2015 has been a year of consolidation, especially for larger transactions with EBITDA is excess of $5,000,000 being bought predominately by private equity buyers.  As the leading healthcare M&A advisor firm it’s a very exciting time for American Healthcare Capital and we expect more of the same throughout 2016.”
Brooks P. Crankshaw, Highland Ridge Capital
“Healthcare has been a strong sector in the M&A market, and we expect that to continue.  According to Reuters, there were 1,577 health care M&A transactions worth $395 billion in the first half of 2015, up 77% (pehub.com, 8/4/2015).  Of course, there were some large transactions that dominated the activity, such as Teva Pharma’s $40.5 billion purchase of Allergan’s generic drug business.  Other notable transactions included Madison Dearborn’s acquisition of Patterson Medical for approximately $715 million.
“Unfortunately, this didn’t translate to increased activity for the PE market.  Of those 1,577 deals in the first half, only 158 of them were PE driven; strategic acquisitions dominated the market during this period.  And, the number of PE transactions was down 37% from the prior year (pehub.com, 8/4/2015).  We expect this trend to continue for larger transactions.
“Anecdotally, our view is that purchase multiples have risen to levels that make it difficult to attain acceptable returns for PE firms.  Strategics, on the other hand, have the ability to recognize the efficiencies of an acquisition with their core business(es), making the higher multiples feasible.
“In the smaller end of the market (revenues of $10-50 million), where Highland Ridge focuses, multiples are relatively lower.  For these smaller companies, there exists higher M&A interest from PE firms versus strategics.  If one were able to segment the market in this manner, we believe it would be clear that PE M&A would dominate for relatively smaller transactions.
Tom Schramski, Vertess
“The M&A marketplace remains very strong in a variety of healthcare verticals and could accelerate through the remainder of 2015 into early 2016, especially in the lower middle market where we see a lot of Baby Boomer executives seeking a transition. Some of the highest multiples can be found in behavioral health/substance abuse treatment, DME, specialty pharmacy and intellectual/developmental disabilities support areas, as well as in services/products that have a primary focus on leveraging technology.
“The underlying foundation for our positive view includes the continuing, rapid development of healthcare technology, the increasing reliance on private enterprise to deliver publicly funded services, the expansion of Medicaid with healthcare reform, and a vibrant consumerism that is adding more private dollars into the mix.
“Add to this the significant number of Baby Boomers yet to transact and we believe the outlook for the near term is very positive for healthcare M&A activity.”

Dexter Braff, The Braff Group
“The Braff Group remains extremely bullish on healthcare M&A for the remainder of the year and into 2016.  With health care reform creating new and exciting opportunities for companies that can effectively manage and coordinate care, we are seeing buyers of many stripes build-out their service capacity through acquisitions.  Whether it’s national nursing home provider Kindred acquiring Gentiva, a national provider of home health and hospice, or UnitedHealth subsidiary Optum acquiring MedExpress, a rapidly growing provider of urgent care, expect to see new and innovative healthcare transaction strategies emerge.  It’s not your father’s M&A market anymore.”
Article LINK
For additional information regarding Florida business sales, acquisitions and valuations, please contact Eric J. Gall at Eric@EdisonAvenue.com or 239.738.6227. Also, visit our Edison Avenue website at www.EdisonAvenue.com or my personal website at www.BuySellFLbiz.com.

Saturday, April 27, 2013

Is My Business Considered Small or Large When it Comes to Healthcare Reform?

Another interesting bit of information shared by Ron Martin of Martin Accounting and CFO Services.

Federal law (Title 13, Part 121 of the Code of Federal Regulations) sets forth in detail the criteria to be used by the Small Business Administration (SBA) in determining the definition of a “Small Business.” This criterion includes items such as sales volume and number of employees. For instance, in most general and heavy construction industries, up to $27.5 million per year in sales receipts qualifies a business as “small,” and in manufacturing, up to 500 employees qualifies a business as “small.”

It’s important to note that this SBA designation doesn’t apply to the Patient Protection and Affordable Care Act (PPACA) – also known as Healthcare Reform. Healthcare Reform mandates that “large” employers will have to offer health insurance to their employees or face fines. To determine if this mandate applies to your business, you are required to look past your SBA designation and understand the rules that are specific to the PPACA.

The PPACA identifies a “large” employer as having 50 full-time employees. Furthermore, while the Fair Labor Standards Act (FLSA) sets 40 hours per week as a standard work week, PPACA sets “full time” at an average of 30 hours per week, per month.

Starting in 2014, employers with more than 50 full-time equivalent (FTE) employees will be fined $2,000 per full-time employee (excluding the first 30 employees), if they do not offer health insurance to employees who average 30-or-more hours per week.

All of this is certainly a lot to consider for that “small business” but “large employer.”

Full Time vs. Full-Time Equivalent
The number of full-time employees at your business determines your health insurance coverage requirements. First, you have to determine the number of employees who work at least 30 hours per week and add them together. Then, for employees who work less than 30 hours per week, take the number of hours they work during the month and divide that by 130 (number of hours worked per month to determine a FTE). Example: If you have 30 employees who each work 30-or-more hours per week, and 26 employees who each work 25 hours per week, the calculation would look like this:



In this example, you have a total of 50 full-time equivalent employees, and you’re expected to provide health insurance even though you don’t have 50 employees working 30 or more hours per week.

Additionally, your number of full-time equivalent employees determines your tax credit qualification. For purposes of figuring out your FTEs, you would use a similar calculation as above, but you would use a 40-hour week as your base. An employee who works 40 hours per week for 52 weeks, works 2,080 hours per year. For employees working less than 40 hours per week, add the estimated number of hours worked and divide that number by 2,080. In the example below, this business has 15 full-time employees working a traditional 40-hour week, 15 full-time employees working a 30-hour week and 25 part-time employees working a 25-hour week.

You will note how the calculations change from “month” to “year” (120 hours/month * 12 months), is not the same calculation as (30 hours/week * 52 weeks), further complicating the math.


Other Reform Considerations
Under the law, healthcare also has to be affordable, which is defined as not more than 9.5% of your employee’s household income. If insurance costs more than that, employees will be able to purchase insurance through an Exchange, which has penalty ramifications for your business. However, large employers typically do not maintain (and would find it difficult to obtain) the “household incomes” of their full-time employees. As a result, the proposed regulations permit employers to use a safe harbor, including an employee’s W-2 wages in lieu of “household” wages to determine affordability.

Implications for Your Managers
Outside of the additional financial considerations placed on businesses as a result of Healthcare Reform, there are some real administrative concerns to face. Managers have always been responsible for managing the number of hours their employees work, but now, failing to control the number of hours has ramifications beyond exceeding operational budgets.

Because of the ramifications of increasing FTE counts, businesses likely will employ a greater number of contingent and seasonal employees who do not need to be included in these counts. The manager’s job, in these situations, becomes more complicated, because shifts have to be planned more efficiently to avoid any unnecessary hours. Specific attention has to be focused on those employees who regularly work close to 30 hours, to avoid unintentionally exceeding the 30-hour mark and therefore, increasing expenses. The U.S. Department of Labor has not yet issued guidance on how long an employee has to work an average of 30 hours per week before it would consider that employee full-time, although it does appear it is making two considerations—one concerning newly hired employees and one concerning established employees.

Additionally, there is a heightened emphasis on employee performance management to get the most efficient use of employee time. This new reality also will force managers to pay more attention to their own schedules, and to accept the likelihood that they’ll be working more hours.

The role of the manager is about to get a lot more complicated. Scheduling has to be well-managed and documented, performance management has to become more rigorous and effective and managers will have to be comfortable communicating these concepts to their employees.

While accurate time-keeping records have always been a requirement under the FLSA, the accuracy of those records now takes on greater importance given the fact that the number of hours employees work drives so much of the eligibility and potential liability under Healthcare Reform.

Author:
Patrick Carey
Professional Employer Consultant
Oasis Outsourcing
604 Courtland Street
Suite 180
Orlando, Florida 32804
Tel: 407-599-4077 x 126
Cell: 407-883-9659
Fax: 855-750-1942
www.OasisAdvantage.com


For additional information regarding Florida business sales, acquisitions and valuations, please contact Eric J. Gall at info@buysellflbiz.com or 239.738.6227. Also, visit our Florida Business Exchange website at www.fbxbrokers.com and my personal website at www.buysellflbiz.com.